SE459556B - Anvaendning av immobiliserat pepsin foer avlaegsnande av immunkonplex ur blod - Google Patents

Anvaendning av immobiliserat pepsin foer avlaegsnande av immunkonplex ur blod

Info

Publication number: SE459556B
Authority: SE; Sweden
Prior art keywords: plasma; pepsin; blood; immobilized; use according
Prior art date: 1982-05-31

Application number

SE8306424A

Other languages

English (en)

Swedish (sv)

Other versions

SE8306424D0 (sv

SE8306424L (sv

Inventor

H Ohnishi

H Kosuzume

Y Suzuki

E Mochida

Original Assignee

Mochida Pharm Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-05-31

Filing date

1983-11-21

Publication date

1989-07-17

1983-11-21 Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd

1983-11-21 Publication of SE8306424D0 publication Critical patent/SE8306424D0/xx

1985-05-22 Publication of SE8306424L publication Critical patent/SE8306424L/

1989-07-17 Publication of SE459556B publication Critical patent/SE459556B/sv

Links

210000004369 blood Anatomy 0.000 title claims description 26
239000008280 blood Substances 0.000 title claims description 26
102000057297 Pepsin A Human genes 0.000 claims description 42
108090000284 Pepsin A Proteins 0.000 claims description 42
229940111202 pepsin Drugs 0.000 claims description 42
238000000034 method Methods 0.000 claims description 11
239000011521 glass Substances 0.000 claims description 10
239000011324 bead Substances 0.000 claims description 9
108090000790 Enzymes Proteins 0.000 claims description 8
102000004190 Enzymes Human genes 0.000 claims description 8
229940088598 enzyme Drugs 0.000 claims description 8
102000004506 Blood Proteins Human genes 0.000 claims description 7
108010017384 Blood Proteins Proteins 0.000 claims description 7
208000024781 Immune Complex disease Diseases 0.000 claims description 6
229920002684 Sepharose Polymers 0.000 claims description 5
238000009256 replacement therapy Methods 0.000 claims description 5
239000013543 active substance Substances 0.000 claims description 4
208000024326 hypersensitivity reaction type III disease Diseases 0.000 claims description 4
210000000265 leukocyte Anatomy 0.000 claims description 4
239000012528 membrane Substances 0.000 claims description 4
208000025883 type III hypersensitivity disease Diseases 0.000 claims description 4
210000002700 urine Anatomy 0.000 claims description 4
230000010412 perfusion Effects 0.000 claims description 3
238000002360 preparation method Methods 0.000 claims description 3
229920000936 Agarose Polymers 0.000 claims description 2
239000003937 drug carrier Substances 0.000 claims description 2
239000000463 material Substances 0.000 claims description 2
230000035790 physiological processes and functions Effects 0.000 claims 1
108010047320 Pepsinogen A Proteins 0.000 description 13
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
239000000243 solution Substances 0.000 description 12
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
239000000203 mixture Substances 0.000 description 9
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
230000009471 action Effects 0.000 description 7
239000000725 suspension Substances 0.000 description 7
235000017557 sodium bicarbonate Nutrition 0.000 description 6
229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
239000003463 adsorbent Substances 0.000 description 5
230000003247 decreasing effect Effects 0.000 description 5
201000010099 disease Diseases 0.000 description 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
239000007864 aqueous solution Substances 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
206010039073 rheumatoid arthritis Diseases 0.000 description 4
241000700159 Rattus Species 0.000 description 3
210000000601 blood cell Anatomy 0.000 description 3
239000012153 distilled water Substances 0.000 description 3
230000000694 effects Effects 0.000 description 3
239000012847 fine chemical Substances 0.000 description 3
206010025135 lupus erythematosus Diseases 0.000 description 3
239000002504 physiological saline solution Substances 0.000 description 3
238000003756 stirring Methods 0.000 description 3
GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 2
108010093096 Immobilized Enzymes Proteins 0.000 description 2
239000004677 Nylon Substances 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
102000007562 Serum Albumin Human genes 0.000 description 2
108010071390 Serum Albumin Proteins 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
239000008351 acetate buffer Substances 0.000 description 2
229920002301 cellulose acetate Polymers 0.000 description 2
238000001914 filtration Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
238000002347 injection Methods 0.000 description 2
201000008383 nephritis Diseases 0.000 description 2
229920001778 nylon Polymers 0.000 description 2
230000001717 pathogenic effect Effects 0.000 description 2
WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
239000008363 phosphate buffer Substances 0.000 description 2
LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
239000000126 substance Substances 0.000 description 2
230000009885 systemic effect Effects 0.000 description 2
201000000596 systemic lupus erythematosus Diseases 0.000 description 2
210000003462 vein Anatomy 0.000 description 2
NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
206010067484 Adverse reaction Diseases 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
201000001320 Atherosclerosis Diseases 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
241000700199 Cavia porcellus Species 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
206010018910 Haemolysis Diseases 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
241000282412 Homo Species 0.000 description 1
241001262617 Japonica Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
241001494479 Pecora Species 0.000 description 1
241000700157 Rattus norvegicus Species 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
101100020289 Xenopus laevis koza gene Proteins 0.000 description 1
CWGJBBRZFIPXNZ-UHFFFAOYSA-N [C-]#N.Br Chemical compound [C-]#N.Br CWGJBBRZFIPXNZ-UHFFFAOYSA-N 0.000 description 1
238000010306 acid treatment Methods 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
230000006838 adverse reaction Effects 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
230000037396 body weight Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
230000008859 change Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
230000008021 deposition Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
210000003191 femoral vein Anatomy 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
238000005227 gel permeation chromatography Methods 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
230000008588 hemolysis Effects 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
208000002672 hepatitis B Diseases 0.000 description 1
239000012510 hollow fiber Substances 0.000 description 1
IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
229940125721 immunosuppressive agent Drugs 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
238000011835 investigation Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
IWHIKEQZPPYMOH-UHFFFAOYSA-N methyl 11-aminoundecanoate;hydrochloride Chemical compound Cl.COC(=O)CCCCCCCCCCN IWHIKEQZPPYMOH-UHFFFAOYSA-N 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
229960001412 pentobarbital Drugs 0.000 description 1
238000000554 physical therapy Methods 0.000 description 1
230000035479 physiological effects, processes and functions Effects 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
238000005086 pumping Methods 0.000 description 1
239000012264 purified product Substances 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
230000029058 respiratory gaseous exchange Effects 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
235000010288 sodium nitrite Nutrition 0.000 description 1
239000011877 solvent mixture Substances 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
108010079570 uropepsin Proteins 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
- B01J20/28033—Membrane, sheet, cloth, pad, lamellar or mat
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
- B01J20/28033—Membrane, sheet, cloth, pad, lamellar or mat
- B01J20/28038—Membranes or mats made from fibers or filaments
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/3092—Packing of a container, e.g. packing a cartridge or column
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3204—Inorganic carriers, supports or substrates
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3206—Organic carriers, supports or substrates
- B01J20/3208—Polymeric carriers, supports or substrates
- B01J20/3212—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3244—Non-macromolecular compounds
- B01J20/3246—Non-macromolecular compounds having a well defined chemical structure
- B01J20/3248—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
- B01J20/3274—Proteins, nucleic acids, polysaccharides, antibodies or antigens
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/58—Use in a single column
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/64—In a syringe, pipette, e.g. tip or in a tube, e.g. test-tube or u-shape tube
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/80—Aspects related to sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J2220/86—Sorbents applied to inner surfaces of columns or capillaries

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Analytical Chemistry (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Molecular Biology (AREA)
Virology (AREA)
Developmental Biology & Embryology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Epidemiology (AREA)
Cell Biology (AREA)
Hematology (AREA)
Pharmacology & Pharmacy (AREA)
External Artificial Organs (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SE8306424A 1982-05-31 1983-11-21 Anvaendning av immobiliserat pepsin foer avlaegsnande av immunkonplex ur blod SE459556B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/JP1982/000212 WO1983004180A1 (fr)	1982-05-31	1982-05-31	Pepsine immobilisee pour l'extraction du complexe immun du sang et procede d'extraction du complexe immun du sang utilisant la pepsine immobilisee

Publications (3)

Publication Number	Publication Date
SE8306424D0 SE8306424D0 (sv)	1983-11-21
SE8306424L SE8306424L (sv)	1985-05-22
SE459556B true SE459556B (sv)	1989-07-17

Family

ID=13762277

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8306424A SE459556B (sv)	1982-05-31	1983-11-21	Anvaendning av immobiliserat pepsin foer avlaegsnande av immunkonplex ur blod

Country Status (10)

Country	Link
US (1)	US4608253A (fr)
EP (1)	EP0110995B1 (fr)
BE (1)	BE898329A (fr)
CA (1)	CA1222452A (fr)
CH (1)	CH664496A5 (fr)
DE (1)	DE3249491T1 (fr)
GB (1)	GB2131028B (fr)
NL (1)	NL8220181A (fr)
SE (1)	SE459556B (fr)
WO (1)	WO1983004180A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4627915A (en) *	1983-04-06	1986-12-09	Asahi Kasei Kogyo Kabushiki Kaisha	Absorbent of autoantibody and immune complexes, adsorbing device and blood purifying apparatus comprising the same
IT1186766B (it) *	1985-11-08	1987-12-16	Sclavo Spa	Metodo per la preparazione di immunoglobuline per uso endovenoso
CA1327963C (fr) *	1987-09-08	1994-03-22	Ryuichi Yokohari	Absorbant d'autoanticorps et appareil pour retirer les autoanticorps a l'aide de cette substance
AT391810B (de) *	1988-02-26	1990-12-10	Immuno Ag	Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
US5593897A (en) *	1988-04-04	1997-01-14	Northwestern University	Binding of immune complexes by modified forms of C-reactive protein
EP3669888B1 (fr) *	2018-12-20	2025-09-24	Gambro Lundia AB	Dispositifs extracorporels pour procédés pour le traitement de maladies associées à des anticorps cytoplasmiques anti-neutrophiles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3746622A (en) *	1971-05-12	1973-07-17	Xerox Corp	Composition and process
JPS5138195A (en) *	1974-09-27	1976-03-30	Osaka Prefecture	Reezakonyoru anaakekakohoho
JPS52151723A (en) *	1976-06-12	1977-12-16	Green Cross Corp:The	L-asparaginase preparations and container for same
JPS52155888A (en) *	1976-06-22	1977-12-24	Mitsui Toatsu Chemicals	Device for continuously removing material in blood flow
DE2828549A1 (de) *	1978-06-29	1980-01-17	Fresenius Chem Pharm Ind	Apparat fuer blutbehandlung
DE2840655C2 (de) *	1978-09-19	1982-06-16	Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG Apparatebau KG, 6380 Bad Homburg	Vorrichtung zur Blutentgiftung
IT1122388B (it) *	1979-08-01	1986-04-23	Anic Spa	Procedimento per la preparazione di materiali biocompatibili tramite l'immobilizzazione superficiale di apirasi
JPS5713266A (en) *	1980-06-27	1982-01-23	Diesel Kiki Co Ltd	Fuel injection device
DE3249251C2 (de) *	1982-02-09	1985-05-09	Mochida Pharmaceutical Co., Ltd., Tokio/Tokyo	Therapeutische Mittel zur Behandlung von allergischen St¦rungen, Immunkomplexerkrankungen und Tumoren

1982
- 1982-05-31 DE DE19823249491 patent/DE3249491T1/de not_active Ceased
- 1982-05-31 NL NL8220181A patent/NL8220181A/nl not_active Application Discontinuation
- 1982-05-31 WO PCT/JP1982/000212 patent/WO1983004180A1/fr not_active Ceased
- 1982-05-31 US US06/556,709 patent/US4608253A/en not_active Expired - Fee Related
- 1982-05-31 CH CH339/84A patent/CH664496A5/de not_active IP Right Cessation
- 1982-05-31 EP EP82901625A patent/EP0110995B1/fr not_active Expired
- 1982-05-31 GB GB08332856A patent/GB2131028B/en not_active Expired
1983
- 1983-11-21 SE SE8306424A patent/SE459556B/sv not_active IP Right Cessation
- 1983-11-29 CA CA000442147A patent/CA1222452A/fr not_active Expired
- 1983-11-29 BE BE0/211947A patent/BE898329A/fr not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA1222452A (fr)	1987-06-02
EP0110995A1 (fr)	1984-06-20
DE3249491T1 (de)	1984-04-19
SE8306424D0 (sv)	1983-11-21
WO1983004180A1 (fr)	1983-12-08
BE898329A (fr)	1984-05-29
GB2131028B (en)	1985-07-03
EP0110995A4 (fr)	1984-09-13
GB8332856D0 (en)	1984-01-18
NL8220181A (nl)	1984-04-02
GB2131028A (en)	1984-06-13
CH664496A5 (de)	1988-03-15
US4608253A (en)	1986-08-26
SE8306424L (sv)	1985-05-22
EP0110995B1 (fr)	1988-09-07

Legal Events

Date

Code

Title

Description

1995-01-31

NUG

Patent has lapsed

Ref document number: 8306424-6

Effective date: 19930109

Format of ref document f/p: F

Publication	Publication Date	Title
JP2807197B2 (ja)	1998-10-08	水性液体からの腫瘍壊死因子αおよび細菌リポ多糖の同時除去方法
US4321192A (en)	1982-03-23	Fractionation of protein mixtures by salt addition followed by dialysis treatment
Terman et al.	1976	Specific removal of DNA antibodies in vivo with an extracorporeal immuno-adsorbent
US20110094962A1 (en)	2011-04-28	Regeneratable filter for extracorporal treatment of liquids containing particles and use thereof
JP2000501949A (ja)	2000-02-22	体外搬出法のための患者特異性免疫吸着剤およびその製出法
SE459556B (sv)	1989-07-17	Anvaendning av immobiliserat pepsin foer avlaegsnande av immunkonplex ur blod
Terman et al.	1977	Specific removal of DNA antibodies in vivo by extracorporeal circulation over DNA immobilized in collodion charcoal
Behm et al.	1989	Selective and specific adsorbents for medical therapy
Blozis et al.	1962	Glomerular basement membrane changes with the nephrotic syndrome produced in the rat by homologous kidney and hemophilus pertussis vaccine
IT8349398A1 (it)	1985-05-29	"pepsina immorilizzata per l'impiego nella eliminazione di immunocomplessi dal sangue e procedimento per eliminare immunocomplessi dal sangue impiegando la pepsina immobilizzata.
Nilsson et al.	1990	Extracorporeal immunoadsorption therapy on rats. In vivo depletion of specific antibodies
Singh et al.	1982	Preparation and in vitro evaluation of a new extracorporeal dialyzer with immobilized insulin
JP2001087381A (ja)	2001-04-03	新規体外循環システムおよびそれを用いた人工臓器補助システム
JPH0523280B2 (fr)	1993-04-02
JPS5980612A (ja)	1984-05-10	免疫制御作用を有するペプタイドの製造方法
JPWO1983004180A1 (ja)	1984-02-02	血中免疫複合体除去用材
Gao et al.	1995	Clinical trials of immunoadsorbent in systemic lupus erythematosus therapy
Hiepe et al.	1990	Development of a C1q-adsorbent for the selective removal of circulating immune complexes
Larue et al.	1985	Suitable hollow fibre immunobioreactors for specific ex vivo removal of antibodies and antigens from plasma
US20040023340A1 (en)	2004-02-05	Method for producing human anti-thymocyte immunoglobulins
Brizgys et al.	1989	Removal of digoxin from the circulation using immobilized monoclonal antibodies
JP3106509B2 (ja)	2000-11-06	抗ヒトリンパ球抗体の製造方法
Sher, Ruben, Wadee, AA, Mason, PR and Fripp	1980	Cytotoxic effect of human eosinophils and eosinophil lysate on Schistosoma haematobium ova
CA1303295C (fr)	1992-06-09	Agent immunosuppresseur et methode d'extraction dudit agent
Klinkmann et al.	1989	Removal of low density lipoproteins (LDL) from plasma: the state of the art